These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26619387)

  • 1. Suggested Guidelines for Reporting Keratoprosthesis Results: Consensus Opinion of the Cornea Society, Asia Cornea Society, EuCornea, PanCornea, and the KPRO Study Group.
    Belin MW; Güell JL; Grabner G
    Cornea; 2016 Feb; 35(2):143-4. PubMed ID: 26619387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes After Auro Keratoprosthesis Implantation: A Low-Cost Design Based on the Boston Keratoprosthesis.
    Venugopal A; Rathi H; Rengappa R; Ravindran M; Raman R
    Cornea; 2016 Oct; 35(10):1285-8. PubMed ID: 27429086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.
    Chan CC; LoVerde L; Qiang J; Nordlund ML; Holland EJ
    Cornea; 2016 Aug; 35(8):1049-56. PubMed ID: 27391092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium term results in keratoprostheses with biocompatible and biological haptic.
    Hille K; Hille A; Ruprecht KW
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):696-704. PubMed ID: 16308693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1.
    Kanellopoulos AJ; Asimellis G
    Cornea; 2014 Sep; 33(9):914-8. PubMed ID: 25014143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eyelid procedures in patients who have undergone Boston keratoprosthesis surgery.
    Baker MS; Krakauer M; Gupta S; de la Cruz J; Cortina MS; Kitzmann AS; Goins KM; Allen RC; Setabutr P
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):286-8. PubMed ID: 22689137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft.
    Hou JH; de la Cruz J; Djalilian AR
    Cornea; 2012 Dec; 31(12):1432-5. PubMed ID: 22236785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Forward Light Scatter by the Boston Keratoprosthesis in Various Configurations.
    Abdelaziz M; Dohlman CH; Sayegh RR
    Cornea; 2017 Jun; 36(6):732-735. PubMed ID: 28476052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular Light Scatter in Eyes With the Boston Type 1 Keratoprosthesis.
    Karas FI; Arteaga A; Barrionuevo P; Cao D; McAnany JJ; Shorter E; Cortina MS
    Cornea; 2019 Jan; 38(1):50-53. PubMed ID: 30157051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience.
    Wang Q; Harissi-Dagher M
    Am J Ophthalmol; 2014 Dec; 158(6):1297-1304.e1. PubMed ID: 25174898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt.
    Utine CA; Tzu JH; Akpek EK
    Ocul Immunol Inflamm; 2011 Dec; 19(6):413-8. PubMed ID: 22106908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreoretinal aspects of permanent keratoprosthesis.
    Klufas MA; Yannuzzi NA; D'Amico DJ; Kiss S
    Surv Ophthalmol; 2015; 60(3):216-28. PubMed ID: 25890625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Boston keratoprosthesis in herpetic keratitis.
    Khan BF; Harissi-Dagher M; Pavan-Langston D; Aquavella JV; Dohlman CH
    Arch Ophthalmol; 2007 Jun; 125(6):745-9. PubMed ID: 17562983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Boston keratoprosthesis].
    Wang L; Huang Y; James C; Dohlman CH
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):307-12. PubMed ID: 24931158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.